- NKTR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $24.6 million.
- NKTR has traded 356,119 shares today.
- NKTR is up 7.2% today.
- NKTR was down 6% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in NKTR with the Ticky from Trade-Ideas. See the FREE profile for NKTR NOW at Trade-Ideas More details on NKTR: Nektar Therapeutics, a biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising oncology, pain, anti-infectives, and immunology. Currently there are 7 analysts that rate Nektar Therapeutics a buy, 1 analyst rates it a sell, and none rate it a hold. The average volume for Nektar Therapeutics has been 1.5 million shares per day over the past 30 days. Nektar has a market cap of $1.3 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.46 and a short float of 13.5% with 5.81 days to cover. Shares are down 34.6% year-to-date as of the close of trading on Thursday.